Rheumatoid arthritis: Threshold for success in RA drug development.
Level V
Where this comes from
- Record sourced from PubMed, PMID 22964534.
- Also identified by DOI 10.1038/nrrheum.2012.150.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Determining the potential success of investigational therapies for rheumatoid arthritis early in the development process would enable better allocation of increasingly limited resources. Such ‘go or no-go’ decision-making could be improved by a method of analysing longitudinal clinical trial data to establish a threshold for success of a new drug.
Medical subject headings
- Arthritis, Rheumatoid
- Decision Support Techniques
- Randomized Controlled Trials as Topic